FI60213C - Foerfarande foer framstaellning av 3-cefem-3-sulfonatestrar - Google Patents

Foerfarande foer framstaellning av 3-cefem-3-sulfonatestrar Download PDF

Info

Publication number
FI60213C
FI60213C FI993/74A FI99374A FI60213C FI 60213 C FI60213 C FI 60213C FI 993/74 A FI993/74 A FI 993/74A FI 99374 A FI99374 A FI 99374A FI 60213 C FI60213 C FI 60213C
Authority
FI
Finland
Prior art keywords
cephem
carboxylic acid
ester
solution
hydroxy
Prior art date
Application number
FI993/74A
Other languages
English (en)
Finnish (fi)
Other versions
FI99374A (
FI60213B (fi
Inventor
Wayne Alfred Spitzer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI99374A publication Critical patent/FI99374A/fi
Publication of FI60213B publication Critical patent/FI60213B/fi
Application granted granted Critical
Publication of FI60213C publication Critical patent/FI60213C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FI993/74A 1974-02-06 1974-04-01 Foerfarande foer framstaellning av 3-cefem-3-sulfonatestrar FI60213C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/439,207 US3985737A (en) 1974-02-06 1974-02-06 3-Sulfonate esters of cephalosporin
US43920774 1974-02-06

Publications (3)

Publication Number Publication Date
FI99374A FI99374A ( ) 1975-08-07
FI60213B FI60213B (fi) 1981-08-31
FI60213C true FI60213C (fi) 1981-12-10

Family

ID=23743737

Family Applications (1)

Application Number Title Priority Date Filing Date
FI993/74A FI60213C (fi) 1974-02-06 1974-04-01 Foerfarande foer framstaellning av 3-cefem-3-sulfonatestrar

Country Status (35)

Country Link
US (1) US3985737A ( )
JP (1) JPS6123198B2 ( )
AR (1) AR207327A1 ( )
AT (1) AT329182B ( )
BE (1) BE813170A ( )
BG (1) BG25998A3 ( )
BR (1) BR7404086A ( )
CA (1) CA1019322A ( )
CH (1) CH596224A5 ( )
CS (1) CS185638B2 ( )
DD (1) DD117466A5 ( )
DE (1) DE2417987A1 ( )
DK (1) DK119974A ( )
EG (1) EG11160A ( )
ES (1) ES427236A1 ( )
FI (1) FI60213C ( )
FR (1) FR2269926B1 ( )
GB (1) GB1457668A ( )
GT (1) GT197432531A ( )
HU (1) HU170811B ( )
IE (1) IE39068B1 ( )
IL (1) IL44360A ( )
IN (1) IN139919B ( )
MW (1) MW1174A1 ( )
NL (1) NL7403127A ( )
NO (2) NO741092L ( )
OA (1) OA04642A ( )
PH (1) PH11197A ( )
PL (1) PL90985B1 ( )
RO (1) RO63020A ( )
SE (1) SE414769B ( )
SU (1) SU576946A3 ( )
YU (1) YU35891B ( )
ZA (1) ZA741424B ( )
ZM (1) ZM5574A1 ( )

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0645625B2 (ja) * 1984-12-28 1994-06-15 塩野義製薬株式会社 ヒドロキシセフアムカルボン酸エステルの製造法
US5245027A (en) * 1989-11-21 1993-09-14 Bristol-Myers Squibb Company 3-fluorosulfonyloxyceph-3-em compounds
US5043439A (en) * 1990-03-08 1991-08-27 Bristol-Myers Squibb Company Process for production of cephalosporins
AR035728A1 (es) * 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241657A (en) * 1967-08-21 1971-08-04 Glaxo Lab Ltd Improvements in or relating to cephalosporin compounds

Also Published As

Publication number Publication date
GT197432531A (es) 1975-09-25
DK119974A ( ) 1975-09-29
CH596224A5 ( ) 1978-03-15
SE7403306L ( ) 1975-08-07
AU6640474A (en) 1975-09-11
IL44360A0 (en) 1974-06-30
NL7403127A (nl) 1975-08-08
MW1174A1 (en) 1975-05-13
IL44360A (en) 1977-06-30
YU63274A (en) 1981-02-28
ZA741424B (en) 1975-10-29
US3985737A (en) 1976-10-12
ATA312274A (de) 1975-07-15
BE813170A (fr) 1974-10-02
ES427236A1 (es) 1976-07-16
CS185638B2 (en) 1978-10-31
IE39068L (en) 1975-08-06
IE39068B1 (en) 1978-08-02
FI99374A ( ) 1975-08-07
DE2417987A1 (de) 1975-08-07
SU576946A3 (ru) 1977-10-15
HU170811B (hu) 1977-09-28
NO741092L ( ) 1975-09-01
FI60213B (fi) 1981-08-31
EG11160A (en) 1977-01-31
CA1019322A (en) 1977-10-18
BG25998A3 ( ) 1979-01-12
PL90985B1 ( ) 1977-02-28
BR7404086A (pt) 1976-01-27
JPS6123198B2 ( ) 1986-06-04
SE414769B (sv) 1980-08-18
OA04642A (fr) 1980-07-31
RO63020A (fr) 1978-07-15
ZM5574A1 (en) 1977-04-21
PH11197A (en) 1977-10-28
AR207327A1 (es) 1976-09-30
FR2269926B1 ( ) 1978-06-30
GB1457668A (en) 1976-12-08
FR2269926A1 ( ) 1975-12-05
NO792632L (no) 1975-08-07
YU35891B (en) 1981-08-31
AT329182B (de) 1976-04-26
JPS50108288A ( ) 1975-08-26
DD117466A5 ( ) 1976-01-12
IN139919B ( ) 1976-08-21

Similar Documents

Publication Publication Date Title
US3925372A (en) Alpha-aminoacyl-3-halo cephalosporins
US3992377A (en) 3-Thio-substituted cephalosporin antibiotics
FI56686C (fi) Foerfarande foer framstaellning av 7-aminocefalosporansyraderivat med antibiotisk verkan
CZ297565B6 (cs) Zpusob prípravy cefem-derivátu
FI63035B (fi) Foerfarande foer framstaellning av 7-alfa-aminoacyl-3-klorcefalosporinderivat
EP0333154B1 (en) Process for the preparation of cephem derivatives
US4064343A (en) 3-Halo cephalosporins
Albrecht et al. Dual-action cephalosporins: cephalosporin 3'-quaternary ammonium quinolones
FI60213C (fi) Foerfarande foer framstaellning av 3-cefem-3-sulfonatestrar
US3917588A (en) {60 -Aminoacyl cephalosporin ethers
GB2173798A (en) Cephalosporanic acid derivatives
FI63240C (fi) Analogifoerfarande foer framstaellning av antibakteriella 3-klorcefalosporinderivat
US4281117A (en) Process for 3-chloro cephalosporin nucleus
US4081595A (en) Reduction giving 3-cephem compounds
US4208515A (en) 3-Halo cephalosporins
KR870000528B1 (ko) 3-아지도 세팔로스포린의 제조방법
US4501741A (en) Cephalosporin antibiotics
US4699981A (en) Cephalosporin derivatives
US4334065A (en) Cephalosporin intermediates
HU189774B (en) Process for producing of 1-oxa-beta-lactame derivates
US4281116A (en) 3-Halo cephalosporins
JP2904810B2 (ja) 7―チアゾリルアセトアミド―3―プロペニルセフェム誘導体
MINAMI et al. Semisynthetic β-Lactam Antibiotics. IX. Synthesis and Antibacterial Activity of 7-[2-(2-Aminothiazol-4-yl)-2-sulfoacetamido]-cephalosporanic Acid and Its Derivatives
US4841044A (en) Cephalosporin derivatives
JP2605096B2 (ja) セフェム誘導体